Trial Profile
A 4-Way Placebo And Active Controlled Study To Evaluate The Effects Of Fesoterodine On Cognitive Function In Healthy Elderly Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2013
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Alprazolam
- Indications Generalised anxiety disorder; Overactive bladder; Panic disorder
- Focus Adverse reactions
- 02 Sep 2011 Results presented at the 41st Annual Meeting of the International Continence Society.
- 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.